Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review

• Published in: PharmacoEconomics Vol. 37; no. 5; pp. 669 - 688
• Main Authors: Ruiz-Negrón, Natalia, Menon, Jyothi, King, Jordan B., Ma, Junjie, Bellows, Brandon K.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.05.2019; Springer; Springer Nature B.V
• Subjects: Analgesics - economics; Analgesics - therapeutic use; Care and treatment; Cost analysis; Cost-Benefit Analysis - methods; Cost-Benefit Analysis - standards; Databases, Factual; Diabetes; Diabetic neuropathies; Diabetic neuropathy; Drug therapy; Editorials; Health Administration; Health Economics; Herpes viruses; Humans; Medical Subject Headings-MeSH; Medicine; Medicine & Public Health; Neuralgia; Neuralgia - drug therapy; Neuralgia - economics; Objectives; Outcome Assessment, Health Care; Pain; Peripheral neuropathy; Pharmacoeconomics and Health Outcomes; Primary care; Public Health; Quality of life; Quality of Life Research; Quality-Adjusted Life Years; Studies; Systematic Review; United States; United Kingdom > UK; United States > US

Background Neuropathic pain significantly reduces an individual’s quality of life and places a significant economic burden on society. As such, many cost-effectiveness analyses (CEAs) have been published for treatments available for neuropathic pain. Objectives The primary objective of this systemat...